ArticleInternational journal of clinical oncology2014

Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer.

Yasuhiro Suzuki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.